Your email has been successfully added to our mailing list.

×
0 0.00289053204147549 0.00289053204147549 0.00288968213496518 0 0 -0.0128335883052863 -0.0128335883052863
Stock impact report

Bluebird CEO defends $1.8 million gene therapy price — 'It's really thinking about it differently' [CNBC]

bluebird bio, Inc. (BLUE) 
Last bluebird bio, inc. earnings: 2/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.bluebirdbio.com/investor-overview
Company Research Source: CNBC
Bluebird Bio CEO defends $1.8 million price for gene therapy — 'It's really thinking about it differently' Bluebird Bio Bluebird's therapy, Zynteglo, was approved in Europe earlier this month for patients with beta thalassemia who require regular blood transfusions to manage their disease and have no matching donor for a stem cell transplant. The price tag, set Friday, makes the drug the second most expensive in the world behind Swiss drugmaker Novartis $2.1 million gene therapy Leschly reasoned that the one-time treatment is a game changer for patients, giving them a "lifelong benefit" while avoiding costly blood transfusions every few weeks for the rest of their lives. Bluebird said patients will only have to pay $1.8 million if the treatment works. The company proposed a five-year installment plan, with 315,000 euros, or $356,567, paid upfront and additional payments due only if the treatment proves effective. It's a form of value-based pricing, Leschly said. "Neither Novartis' dr Show less Read more
Impact Snapshot
Event Time:
BLUE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
BLUE alerts

from News Quantified
Opt-in for
BLUE alerts

from News Quantified